Public trial registry of the CCC-Munich

Trial ACTICCA-1

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ACTICCA-1
World
Full title
:

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer (ACTICCA-1)

World
NCT number
:
World
Responsible organization
:
KUM - Chirurgische Klinik und Poliklinik (Großhadern) Lmu
Indications
Classification Code Description
ICD-10-GM C22.- Bösartige Neubildung der Leber und der intrahepatischen Gallengänge
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Responsible contact Markus Rentsch KUM - Chirurgische Klinik und Poliklinik (Großhadern) Magnifier
World Principal Investigator Markus Rentsch KUM - Chirurgische Klinik und Poliklinik (Großhadern) Magnifier